Anti-Recombinant MUC1, clone A309

Item number Size Datasheet Manual SDS Delivery time Quantity Price
E-AN301606L.50 50 µl -

7 - 16 business days*

304.00€
E-AN301606L.100 100 µl -

7 - 16 business days*

464.00€
 
The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion... more
Product information "Anti-Recombinant MUC1, clone A309"
The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack.The beta subunit contains a C-terminal domain which is involved in cell signaling, through phosphorylations and protein-protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B pathways. In activated T-cells, influences directly or indirectly the Ras/MAPK pathway. Promotes tumor progression. Regulates TP53-mediated transcription and determines cell fate in the genotoxic stress response. Binds, together with KLF4, the PE21 promoter element of TP53 and represses TP53 activity.
Keywords: Anti-MUC1, Anti-PEMT, Anti-H23AG, Anti-Mucin-1, Anti-Episialin, Anti-Cancer antigen 15-3, Anti-Tumor-associated mucin, Anti-Krebs von den Lungen-6, Anti-Carcinoma-associated mucin, Anti-Polymorphic epithelial mucin, Anti-Peanut-reactive urinary mucin, Ant
Supplier: Elabscience
Supplier-Nr: E-AN301606L

Properties

Application: WB, IHC
Antibody Type: Monoclonal
Clone: A309
Conjugate: No
Host: Rabbit
Species reactivity: human, rat, mouse
Immunogen: Recombinant human MUC1 fragment
MW: 24 kD

Handling & Safety

Storage: -20°C
Shipping: -20°C (International: -20°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H317
P Phrases: P261, P272, P280, P302+352, P333+313
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-Recombinant MUC1, clone A309"
Write a review
or to review a product.
Viewed